Tetrahydrobiopterin (BH4) has been recently approved as a treatment of patients with phenylketonuria. However, as a confirmation of BH4-responsiveness, it might require a very …
Phenylketonuria (PKU) is an autosomal recessive metabolic disorder caused by deficiency of phenylalanine hydroxylase (PAH). The major molecular defects causing PKU are …
OA Baturina, IV Morozov - Eur J Medicine, 2016 - scholar.archive.org
Results of phenylalanine hydroxylase (PAH) locus molecular genotyping for 115 phenylketonuria (PKU) patients and their family members from Novosibirsk and Kemerovo …
В рамках генетико-эпидемиологического исследования населения Ростовской области (РО) определены спектр и частоты мутаций в гене РАН у больных фенилкетонурией …
OO Soloviov, LA Livshits - Cytology and genetics, 2009 - Springer
The assays were developed for the analysis of the most frequent in Ukraine PAH gene mutations (R158Q, R408W, Y414C, P281L, R252W, and R261Q) in PKU patients and in …